Genomic Vision SA (GV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genomic Vision SA (GV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7301
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomic’s technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements. Genomic is headquartered in Paris, France.

Genomic Vision SA (GV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genomic Vision SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genomic Vision SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genomic Vision SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genomic Vision SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genomic Vision SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genomic Vision SA, Medical Equipment, Deal Details 10
Partnerships 10
European Equity Partners Enters into Licensing Agreement with Genomic Vision 10
Genomic Vision Enters into Agreement with Children’s Medical Research Institute 11
Genomic Vision Enters into Distribution Agreement with AmCare Genomics Laboratory 12
Genomic Vision Enters into Agreement with Reims University Hospital 13
Genomic Vision Extends Agreement with Quest Diagnostics 14
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 15
Equity Offering 16
Genomic Vision Completes IPO For US$32 Million 16
Genomic Vision SA – Key Competitors 17
Genomic Vision SA – Key Employees 18
Genomic Vision SA – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Jan 17, 2018: Genomic Vision: 2017 Annual Revenue from Sales: +36% to €2.1 Million 20
Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to €1.3 Million 21
Jul 25, 2017: Genomic Vision: First half 2017 results 22
May 09, 2017: Genomic Vision: Financial Information at March 31, 2017 24
Mar 01, 2017: Genomic Vision: 2016 Annual Results 25
Government and Public Interest 28
Jul 05, 2018: Genomic Vision Provides an Update on Its Commercial Development and Financial Situation 28
Product News 29
Apr 24, 2018: Genomic Vision Invited to Present FiberVision Platform at the NIST-FDA Genome Editing Workshop in Gaithersburg (Maryland) 29
Oct 18, 2017: Genomic Vision: Report of the LSR R&D Day 30
Jul 27, 2017: Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York 31
Other Significant Developments 32
Jul 12, 2017: Genomic Vision: The Cologne Center for Genetics, a Major European Core Facility in Genetic Analysis, Adopts the Molecular Combing Technology 32
Jun 19, 2017: Genomic Vision Inks Chinese Distribution Deal with APG Bio 33
Jan 09, 2017: Genomic Vision Doubles Its Installed Base of FiberVision Platforms and Quadruples Its Sales of Products and Services in 2016 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Genomic Vision SA, Medical Equipment, Key Facts, 2017 2
Genomic Vision SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genomic Vision SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genomic Vision SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genomic Vision SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genomic Vision SA, Deals By Market, 2012 to YTD 2018 8
Genomic Vision SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
European Equity Partners Enters into Licensing Agreement with Genomic Vision 10
Genomic Vision Enters into Agreement with Children's Medical Research Institute 11
Genomic Vision Enters into Distribution Agreement with AmCare Genomics Laboratory 12
Genomic Vision Enters into Agreement with Reims University Hospital 13
Genomic Vision Extends Agreement with Quest Diagnostics 14
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 15
Genomic Vision Completes IPO For US$32 Million 16
Genomic Vision SA, Key Competitors 17
Genomic Vision SA, Key Employees 18

List of Figures
Genomic Vision SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genomic Vision SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genomic Vision SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genomic Vision SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genomic Vision SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genomic Vision SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genomic Vision SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genomic Vision SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genomic Vision SA (GV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • General Electric Capital Corporation:戦略・SWOT・企業財務分析
    General Electric Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary General Electric Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • U.S. Preventive Medicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Preventive Medicine Inc (USPM) is a healthcare service center that provides wellness and care management services. The center offers preventive plan, a web-based or online health management platform for the clinical science of preventive medicine. Its preventive plan library provides in …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Armstrong World Industries, Inc:企業の戦略・SWOT・財務情報
    Armstrong World Industries, Inc - Strategy, SWOT and Corporate Finance Report Summary Armstrong World Industries, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Oxford Nanopore Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., develops disruptive, electronic, and single-molecule sensing system. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecule …
  • Baltimore Gas and Electric Company-エネルギー分野:企業M&A・提携分析
    Summary Baltimore Gas and Electric Company (BGE), a subsidiary of Exelon Corporation, is a regulated public utility that purchases, transmits, distributes and sells electricity; and purchases, sells and distributes natural gas. The company also offers services such as billing, emergency response, me …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務情報
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sonoma Pharmaceuticals Inc (OCLS):企業の財務・戦略的SWOT分析
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Pudumjee Paper Products Limited:企業の戦略・SWOT・財務情報
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SVB Financial Group:企業のM&A・事業提携・投資動向
    SVB Financial Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SVB Financial Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Heron Resources Ltd:企業の戦略・SWOT・財務分析
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Alliant Energy Corp (LNT):電力:M&Aディール及び事業提携情報
    Summary Alliant Energy Corp (Alliant Energy) is an energy utility holding company. Through subsidiaries, it carries out generation and distribution of electricity and distribution and transportation of natural gas. The company operates through Interstate Power and Light Company (IPL) and Wisconsin P …
  • The Sage Group plc (SGE):企業の財務・戦略的SWOT分析
    The Sage Group plc (SGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Milliken & Company:企業の戦略・SWOT・財務情報
    Milliken & Company - Strategy, SWOT and Corporate Finance Report Summary Milliken & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sekisui Chemical Co Ltd (4204):企業の財務・戦略的SWOT分析
    Sekisui Chemical Co Ltd (4204) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NTT Communications Corporation:戦略・SWOT・企業財務分析
    NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆